SYGNIS signs distribution deal for genome analysis kit in Spain

SYGNIS AG has announced a collaboration agreement with bioNova cientifica, s.l. for the commercialisation of its TruePrime™ Single Cell whole genenome analysis (WGA) kit in Spain. Under the terms of the agreement, bioNova will promote, market, sell and support this kit which is based on SYGNIS’ multiple displacement amplification technology and intended to address demand in fields such as oncology, pathology and clinical diagnostics.

Founded in 1987  bioNova, a specialised provider of products, technologies and instruments for the life sciences markets to customers in Spain is providing the kit in formats of 25 or 100 reactions.

TruePrime™ is based on the combination of the recently discovered polymerase “TthPrimPol” and the extremely processive and high-fidelity Phi29 polymerase to amplify uniformly total genomic DNA for a multitude of applications including next generation sequencing and single cell analysis. It has been reported to work well with all commonly used next generation sequencing platforms such as Illumina and IonTorrent.